Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of cancer drugs in development in the United States in select years between 2005 and 2018

Exclusive Premium Statistic

Number of cancer drugs in development in the U.S. 2005-2018 This statistic depicts the number of cancer drugs in development in the United States in select years between 2005 and 2018. As of May 2018, over 1,100 cancer drugs in development were reported. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).
Show more
Number of cancer drugs
--
--
--
--
--
--
--
--
--
--
Number of cancer drugs
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic depicts the number of cancer drugs in development in the United States in select years between 2005 and 2018. As of May 2018, over 1,100 cancer drugs in development were reported. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).
Show more
Release date
May 2018
Region
United States
Survey time period
2005 to 2018
Special properties
PhRMA members
Supplementary notes
All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA). No data for 2010 and 2013 available. This statistic was assembled from several publications of PhRMA.
* Taken from PhRMA - Medicines in development for cancer (October 2014).
** Taken from PhRMA - Medicines in development for cancer (October 2015).
*** Taken from PhRMA - Medicines in development for cancer (May 2018).
Open this statistic in...
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Oncology
Oncology

All Information
in one Presentation

Oncology

Everything On "Oncology" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Cancer"
  • Overview - Worldwide
  • Overview - United States
  • Incidence rates
  • Death rates
  • Probability of surviving
  • Risk factors
  • Cancer drug market
The most important statistics
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics on the topic
Topics
About Statista
Learn more about how Statista can support your business.
Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News